Northroad Capital Management’s Novartis NVS Stock Holding History

Northroad Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.5M	Sell	21,249 -52,656	-71%	-$3.84M	3.43%	6
2016 Q2	$5.46M	Buy	73,905 +12,887	+21%	+$890K	4.19%	2
2016 Q1	$3.96M	Sell	61,018 -2,832	-4%	-$193K	2.56%	20
2015 Q4	$4.92M	Sell	63,850 -4,578	-7%	-$364K	2.93%	12
2015 Q3	$5.64M	Sell	68,428 -18,014	-21%	-$1.6M	3.32%	4
2015 Q2	$7.62M	Buy	86,442 +2,039	+2%	+$187K	3.92%	2
2015 Q1	$7.46M	Sell	84,403 -22,860	-21%	-$2.03M	3.99%	2
2014 Q4	$8.91M	Sell	107,263 -42,606	-28%	-$3.53M	4.02%	2
2014 Q3	$12.6M	Sell	149,869 -1,320	-0.9%	-$107K	4.88%	1
2014 Q2	$12.3M	Buy	151,189 +2,649	+2%	+$208K	4.28%	1
2014 Q1	$11.3M	Sell	148,540 -30,543	-17%	-$2.23M	4.1%	1
2013 Q4	$12.9M	Sell	179,083 -1,658	-0.9%	-$115K	4.62%	1
2013 Q3	$12.4M	Sell	180,741 -8,365	-4%	-$553K	4.76%	1
2013 Q2	$12M	Buy	+189,106	New	+$12.3M	4.65%	1

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Northroad Capital Management's NVS Position: Q3 2016 in Review

Northroad Capital Management reduced its Novartis (NVS) stake by 71% in Q3 2016, selling an estimated $3.84M and leaving 21,249 shares worth $1.5M. The position accounts for 3.43% of the portfolio, ranked #6.

Northroad Capital Management first reported a position in NVS in Q2 2013 and has held it in 14 quarters since. The position peaked at $12.9M in Q4 2013. 878 funds tracked by Wall St. Rank hold NVS as of Q3 2016.

Northroad Capital Management held 21,249 shares of Novartis worth $1.5M as of Q3 2016.
Northroad Capital Management sold 52,656 Novartis shares in Q3 2016, an estimated $3.84M.
Novartis made up 3.43% of Northroad Capital Management's portfolio in Q3 2016, its #6 holding.
Northroad Capital Management first reported a position in Novartis in Q2 2013 and has held it in 14 quarters since.
Northroad Capital Management's Novartis position peaked at $12.9M in Q4 2013.
878 funds tracked by Wall St. Rank held Novartis as of Q3 2016.

Based on Northroad Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.